|
|
|
|
| LEADER |
01957nam a2200337 u 4500 |
| 001 |
EB000942740 |
| 003 |
EBX01000000000000000736330 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
150223 r ||| eng |
| 020 |
|
|
|a 9780309157711
|
| 020 |
|
|
|a 0309157714
|
| 050 |
|
4 |
|a QH447
|
| 100 |
1 |
|
|a Wizemann, Theresa M.
|
| 245 |
0 |
0 |
|a The value of genetic and genomic technologies
|h Elektronische Ressource
|b workshop summary
|c Theresa Wizemann and Adam C. Berger, rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine of the National Academies
|
| 260 |
|
|
|a Washington, D.C.
|b National Academies Press
|c 2010, c2010
|
| 300 |
|
|
|a xv, 92 p.
|c 23 cm
|
| 505 |
0 |
|
|a Tumor-based screening for Lynch Syndrome -- Pharmacogenomic testing to guide warfarin dosing -- Genomic profiling -- Closing remarks
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Genetic Predisposition to Disease
|
| 653 |
|
|
|a Genetic Testing
|
| 653 |
|
|
|a Genetic Diseases, Inborn / diagnosis
|
| 653 |
|
|
|a Genomics
|
| 700 |
1 |
|
|a Berger, Adam C.
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.)
|b Roundtable on Translating Genomic-Based Research for Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 856 |
4 |
0 |
|u http://www.nap.edu/catalog.php?record_id=12947
|3 Volltext
|n Provider site
|3 Volltext
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK52756
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a "Knowing one's genetic disposition to a variety of diseases, including common chronic diseases, can benefit both the individual and society at large. The IOM's Roundtable on Translating Genomic-Based Research for Health held a workshop on March 22, 2010, to bring together diverse perspectives on the value of genetic testing, and to discuss its use in clinical practice"--Publisher's description
|